Blockchain Registration Transaction Record

Bioelectric Breakthrough Boosts Peptide Delivery by 300% for Longevity

Lionheart Health files patent for bioelectric platform boosting peptide delivery by 300%. Technology enhances oral, topical & injectable peptide absorption for longevity applications.

This development matters because it addresses a fundamental bottleneck in longevity medicine: getting therapeutic peptides to actually reach their cellular targets. Current delivery methods are shockingly inefficient, with up to 99.9% of oral peptides being lost before they can exert biological effects. This inefficiency translates to higher costs, inconsistent results, and limited practical applications for promising anti-aging compounds. By potentially improving bioavailability by 300%, this technology could make peptide therapies more accessible, affordable, and effective for consumers seeking evidence-based longevity interventions. In a field where small improvements in delivery can mean the difference between theoretical promise and practical benefit, this advancement could accelerate the translation of laboratory research into real-world healthspan solutions.